Provista Diagnostics, Inc., a Delaware company, is a privately held molecular diagnostics company offering diagnostic testing and reference clinical laboratory services tot he pharmaceutical and biotechnology industries. Additionally, the company is focused […]
EpiCept Corporation Announces Year End Results and Updates On Clinical Trials Surrounding Cancer Treatment
EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.
Exosome Diagnostics Develops Unique Genetic Based Diagnostics
Exosome Diagnostics is a specialized bio-pharmaceutical company that develops a unique kind of genetic-based diagnostic tests. The company’s technological platform isolates from the blood micro-vesicles produced by cells, and then analyze the […]
NeoGenomics Reports Fourth Quarter and Full Year 2010 Results
FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ — NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.
Killing Canine Cancer:Functional Nutriments Applies Ground-Breaking Therapy To Human Patients (Video)
Cancer, a word that strikes a chord of fear in many, is a fighting word. At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry, and while it is a match we have yet to win, researchers and scientists have on their boxing gloves and are staying in the fight.
ADVENTRX Pharmaceuticals Provides Update on ANX-514
ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates principally for the treatment of cancer, recently provided an update on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel.
Seno Medical Uses Laser-Based Technology For Early cancer Diagnosis
Seno Medical is a company focused on cancer using its new patented opto-acoustic technology. This new imaging modality combines the use of light in and sound out to uniquely obtain the hallmark […]
T-Ray Science Announces Name Change
T-Ray Science, Inc., a medical device company committed to commercializing innovative systems for the early detection of cancer announces that shareholders approved a change of the name of the Company to Verisante Technology, Inc.
